369 related articles for article (PubMed ID: 16313238)
21. Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis.
Chen X; Yang M; Cheng Y; Liu GJ; Zhang M
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009481. PubMed ID: 24151011
[TBL] [Abstract][Full Text] [Related]
22. Broad band UVA: a possible reliable alternative to PUVA in the treatment of early-stage mycosis fungoides.
El Mofty M; Ramadan S; Fawzy MM; Hegazy RA; Sayed S
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):274-7. PubMed ID: 22971197
[TBL] [Abstract][Full Text] [Related]
23. Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides: a retrospective study.
Diederen PV; van Weelden H; Sanders CJ; Toonstra J; van Vloten WA
J Am Acad Dermatol; 2003 Feb; 48(2):215-9. PubMed ID: 12582391
[TBL] [Abstract][Full Text] [Related]
24. A chart review of patients with early stage mycosis fungoides treated with psoralen plus UVA (PUVA).
Soung J; Muigai W; Amin N; Stern DK; Lebwohl MG
J Drugs Dermatol; 2005; 4(3):290-4. PubMed ID: 15898283
[TBL] [Abstract][Full Text] [Related]
25. An observer-blinded randomized controlled pilot trial comparing localized immersion psoralen-ultraviolet A with localized narrowband ultraviolet B for the treatment of palmar hand eczema.
Brass D; Fouweather T; Stocken DD; Macdonald C; Wilkinson J; Lloyd J; Farr PM; Reynolds NJ; Hampton PJ
Br J Dermatol; 2018 Jul; 179(1):63-71. PubMed ID: 29235664
[TBL] [Abstract][Full Text] [Related]
26. UVB in the management of early stage mycosis fungoides.
Pavlotsky F; Barzilai A; Kasem R; Shpiro D; Trau H
J Eur Acad Dermatol Venereol; 2006 May; 20(5):565-72. PubMed ID: 16684285
[TBL] [Abstract][Full Text] [Related]
27. Plaque stage mycosis fungoides treated with bexarotene at low dosage and UVB-NB.
D'Acunto C; Gurioli C; Neri I
J Dermatolog Treat; 2010 Jan; 21(1):45-8. PubMed ID: 19603308
[TBL] [Abstract][Full Text] [Related]
28. Treatment of stage Ia and Ib mycosis fungoides with psoralen UVA monotherapy: an observational study in tertiary hospitals in the Canary Islands.
Hernández Z; Peñate Y; Hernández-Machín B; Pérez-Méndez L; Suárez-Hernández J; Hernández J; Fernández-de-Misa R
Int J Dermatol; 2014 Nov; 53(11):1417-22. PubMed ID: 24697305
[TBL] [Abstract][Full Text] [Related]
29. Case experience of 308-nm excimer laser therapy compatibility with PUVA and oral bexarotene for the treatment of cutaneous lesions in mycosis fungoides.
Huang J; Cowper S; Moss J; Girardi M
J Drugs Dermatol; 2013 Apr; 12(4):487-9. PubMed ID: 23652902
[TBL] [Abstract][Full Text] [Related]
30. PUVA therapy and narrowband UVB therapy in Tunisian patients with mycosis fungoides.
Khaled A; Fazaa B; Goucha S; Zeglaoui F; Kamoun MR
Therapie; 2009; 64(6):389-94. PubMed ID: 20025842
[TBL] [Abstract][Full Text] [Related]
31. Narrow-band ultraviolet B phototherapy for early stage mycosis fungoides.
Xiao T; Xia LX; Yang ZH; He CD; Gao XH; Chen HD
Eur J Dermatol; 2008; 18(6):660-2. PubMed ID: 18955199
[TBL] [Abstract][Full Text] [Related]
32. Changes in the dermoscopic appearance of melanocytic naevi after photochemotherapy or narrow-band ultraviolet B phototherapy.
Kilinc Karaarslan I; Teban L; Dawid M; Tanew A; Kittler H
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):526-31. PubMed ID: 17373982
[TBL] [Abstract][Full Text] [Related]
33. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS
Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
[TBL] [Abstract][Full Text] [Related]
34. [Narrow band UVB therapy in early stage mycosis fungoides. A study of 23 patients].
Coronel-Pérez IM; Carrizosa-Esquivel AM; Camacho-Martínez F
Actas Dermosifiliogr; 2007 May; 98(4):259-64. PubMed ID: 17506957
[TBL] [Abstract][Full Text] [Related]
35. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 May; 21(5):638-42. PubMed ID: 17447977
[TBL] [Abstract][Full Text] [Related]
36. Folliculotropic mycosis fungoides in a pediatric patient with response to psoralen-ultraviolet A phototherapy.
Boix-Vilanova J; Corral-Magaña O; Martin-Santiago A; Escalas J
Photodermatol Photoimmunol Photomed; 2019 Jan; 35(1):54-56. PubMed ID: 30007081
[TBL] [Abstract][Full Text] [Related]
37. Bexarotene and narrowband ultraviolet B phototherapy combination treatment for mycosis fungoides.
Lokitz ML; Wong HK
Photodermatol Photoimmunol Photomed; 2007 Dec; 23(6):255-7. PubMed ID: 17986063
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the efficacy of local narrowband ultraviolet B (NB-UVB) phototherapy versus psoralen plus ultraviolet A (PUVA) paint for palmoplantar psoriasis.
Sezer E; Erbil AH; Kurumlu Z; Taştan HB; Etikan I
J Dermatol; 2007 Jul; 34(7):435-40. PubMed ID: 17584319
[TBL] [Abstract][Full Text] [Related]
39. Narrow-band UVB phototherapy and psoralen-ultraviolet A photochemotherapy in the treatment of cutaneous mastocytosis: a study in 20 patients.
Brazzelli V; Grassi S; Merante S; Grasso V; Ciccocioppo R; Bossi G; Borroni G
Photodermatol Photoimmunol Photomed; 2016 Sep; 32(5-6):238-246. PubMed ID: 27353865
[TBL] [Abstract][Full Text] [Related]
40. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R
Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]